Jiangzhong Pharmaceutical Co., Ltd. (600750) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jiangzhong Pharmaceutical Co., Ltd.

Why is Jiangzhong Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 11.68% and Operating profit at 15.28% over the last 5 years

Flat results in Dec 25

RAW MATERIAL COST(Y) Grown by 101.88% (YoY)
DEBT-EQUITY RATIO (HY) Highest at 0 %
DEBTORS TURNOVER RATIO(HY) Lowest at 0 times

With ROE of 22.88%, it has a very attractive valuation with a 3.51 Price to Book Value

Over the past year, while the stock has generated a return of 16.21%, its profits have risen by 12.2% ; the PEG ratio of the company is 1.2
At the current price, the company has a high dividend yield of 5.5

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Jiangzhong Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Jiangzhong Pharmaceutical Co., Ltd.

1.59%

-0.27

16.45%

China Shanghai Composite

16.78%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

9.54%

EBIT Growth (5y)

13.94%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.41

Sales to Capital Employed (avg)

1.05

Tax Ratio

15.82%

Dividend Payout Ratio

95.69%

Pledged Shares

Institutional Holding

ROCE (avg)

43.69%

ROE (avg)

16.29%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.75

EV to EBIT

14.83

EV to EBITDA

13.36

EV to Capital Employed

4.29

EV to Sales

3.80

PEG Ratio

1.41

Dividend Yield

4.67%

ROCE (Latest)

28.91%

ROE (Latest)

22.90%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -1.56% (YoY

PRE-TAX PROFIT(Q)

Highest at CNY 360.25 MM

NET PROFIT(Q)

Highest at CNY 287.81 MM

EPS(Q)

Highest at CNY 0.46

-12What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 922.16 MM

NET SALES(HY)

At CNY 2,322.5 MM has Grown at -12.28%

CASH AND EQV(HY)

Lowest at CNY 1,742.63 MM

DEBT-EQUITY RATIO (HY)

Highest at -16.3 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.48 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.69 times

Here's what is working for Jiangzhong Pharmaceutical Co., Ltd.

Pre-Tax Profit

Highest at CNY 360.25 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 287.81 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.46

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -1.56% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Jiangzhong Pharmaceutical Co., Ltd.

Operating Cash Flow

Lowest at CNY 922.16 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

At CNY 2,322.5 MM has Grown at -12.28%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Cash and Eqv

Lowest at CNY 1,742.63 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at -16.3 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 3.48 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 3.69 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio